Agenus | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
AbbVie USD 5.52B 1.73B 2024-12
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Celldex Therapeutics USD 17.14M 11.22M 2025-03
CSL 1.52B 133M 2024-12
Dynavax Technologies USD 661.34M 565.45M 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
Incyte USD 2.41B 720.83M 2025-03
J&J USD 38.47B 32.35B 2025-03
Jiangsu Hengrui CNY 24.09B 730.2M 2025-03
MacroGenics USD 182.84M 3.22M 2024-12
Merck EUR 1.01B 1.14B 2025-03
Merck USD 8.63B 4.61B 2025-03
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.43B 387M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Veracyte USD 186.12M 52.97M 2025-03



Agenus Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.